Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.4127
-0.0332 (-7.45%)
At close: Nov 20, 2026, 4:00 PM EST
0.4300
+0.0173 (4.19%)
After-hours: Nov 20, 2026, 7:59 PM EST
Invivyd Market Cap
Invivyd has a market cap or net worth of $122.01 million as of November 20, 2026. It is the 23,217th most valuable company in the world and the 3,841st biggest in the United States. Its market cap has decreased by 82.39% in one year.
Market Cap
122.01M
Enterprise Value
3.86M
1-Year Change
-82.39%
Global Rank
Country Rank
#3,841 United States
Category
ChartMarket Cap Chart
Since the IPO on August 6, 2021, Invivyd's market cap has decreased from $1.84B to $122.01M, a decrease of -93.39%. That is a compound annual growth rate of -40.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 122.01M | -82.18% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -56.22% |
| Aug 6, 2021 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 133.64M |
| PolyPid | 129.29M |
| Sionna Therapeutics | 127.79M |
| MacroGenics | 125.26M |
| Compass Therapeutics | 123.94M |
| Humacyte | 123.73M |
| Satellos Bioscience | 122.07M |
| Adagene | 118.17M |